Pregled bibliografske jedinice broj: 1037436
Evaluation of cap-piercing technology for coagulation testing on Sysmex CS-2500 system
Evaluation of cap-piercing technology for coagulation testing on Sysmex CS-2500 system // Clinical Chemistry and Laboratory Medicine
Berlin: Walter de Gruyter, 2019. str. eA60-eA61 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1037436 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Evaluation of cap-piercing technology for coagulation testing on Sysmex CS-2500 system
Autori
Komljenović, Sven ; Zrinski Topić, Renata ; Leniček Krleža, Jasna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ - Berlin : Walter de Gruyter, 2019, EA60-eA61
Skup
5th EFLM Conference on Preanalytical Phase
Mjesto i datum
Zagreb, Hrvatska, 22.03.2019. - 23.03.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Cap-piercing technology ; coagulation ; method comparisson
(cap-piercing technology ; coagulation ; method comparisson)
Sažetak
Background Cap-piercing technology is a mechanism that has emerged in order to improve the laboratory staff safety by reducing exposure to the biological specimen. The aim of the study was to examine whether cap-piercing technology is reliable for routine use since nonreproducible results were previously noticed for coagulation tests, noticeably fibrinogen concentration that was measured by Sysmex® CS-2500 System coagulation analyzer. Materials and Methods Our study collectively used 58 blood samples from pediatric population standardized for coagulation testing which had their Prothrombin time (PT) measured using coagulometric assay (Dade Innovin, Siemens), fibrinogen concentration measured using coagulometric assay (Dade Thrombin, Siemens), D-dimer concentration measured using immunoturbidimetric assay (Innovance D-dimer, Siemens) and/or Protein C activity measured using spectrophotometric assay (Berichrom Protein C, Siemens) from the capped tube and then the decapped tube. Bland-Altman analysis and Passing-Bablok regression analysis have been used to compare results. Results No significant difference has been observed for any of the previously mentioned tests when Bland-Altman analysis (with Westgard's QC rules) has been used: PT had average BIAS = 0.7% (desirable BIAS = 2.0%), fibrinogen had average BIAS = 0.4% (desirable BIAS = 4.8%), Protein C had average BIAS = 0.2% (desirable BIAS = 13.9%) and D-dimer had average BIAS = 0.2% (desirable BIAS = 8.82%). Passing-Bablok regression analysis showed no significant difference for PT (y = [-0.0305 – 0.0000] + [1.0000 – 1.0411] x), Protein C (y = [-2.2598 – 1.1058] + [0.9843 – 1.0217] x) and D-dimer (y = [-0.0249 – 0.0175] + [0.9688 – 1.0235] x). Passing-Bablok regression analysis for fibrinogen showed systematic and proportional differences (y = [0.0087 – 0.0997] + [0.9547 – 0.9935] x). Conclussion We have concluded that cap-piercing technology is acceptable for routine coagulation testing on Sysmex® CS-2500 System.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za dječje bolesti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE